We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Online

ESTRO EORTC OligoCare Workshop

30 June (16:00-19:00 CEST) and 1 July (16:00-17:30 CEST) | Workshop leaders: M. Guckenberger (CH) and P. Ost (BE)
  • Participants will learn about the current clinical status and recent scientific developments in the field of Oligo-Metastatic Disease
  • Participants will learn how to optimise follow-up and data capture in OligoCare
  • Participants will learn about challenging cases treated with SBRT for Oligo-Metastatic Disease
  • Workshop is open to centres participating in OligoCare
  • Radiation oncologists with a clinical and research focus on SBRT and Oligo-Metastatic Disease
  • Medical physicists
  • Radiobiologists with an interest in radiotherapy for metastatic disease

The workshop is free of charge.

30th June: Workshop is full and registration is now closed.

1st July: The workshop on July 1st is open to OligoCare cohort participating centres only. Please click here to register. The link to attend the online workshop is sent to the email address that you specified during the registration process.

 

 Programme 30 June from 16:00-19:00 CEST

Time slot

Title

Speaker

16:00-16:05

Welcome

Matthias Guckenberger (CH) and Piet Ost (BE)

16:05-16:30

Keynote lecture: Past, present and future of OMD, focus on patient identification and biomarker research

Ralph Weichselbaum (US)

16:30-16:50

Will imaging with single-cell resolution improve oligometastatic patient selection in the future?

Guillem Pratx (US)

16:50-17:10

Radical radiotherapy beyond OMD: results from ImmunoSABR trials

Willemijn Theelen (NL)

17:10-17:30

Added value of registry trials to advance OMD research: the UK experience

Nicholas van As (UK)

17:30-17:40

Discussion

  

17:40-17:45

Break

  

17:45-18:05

Challenges of radiotherapy treatment planning for “multiple” oligometastases

Coen Hurkmans (NL)

18:05-18:25

Randomised trials in clinical OMD research: needed and realistic?

David Palma (CA)

18:25-18:50

Keynote lecture: Will better systemic therapy increase or decrease the need for local treatment in (oligo-) metastatic disease?

Rolf Stahel (CH)

18:50-19:00

Discussion

  

 

Programme 1 July from 16:00-17:45 CEST (open mainly to participating centres)

Time slot

Title

Speaker

16:00-16:25

Overview of the current status and preliminary results of OligoCare

Matthias Guckenberger (CH)

16:25-16:40

Sharing experiences from OligoCare: challenges of patient selection

Piet Ost (BE)

16:40-16:55

Optimising data quality in OligoCare

Nicolas Sauve (BE)

16:55-17:10

Sharing experiences from OligoCare: secrets of successful recruitment

Filippo Alongi (IT)

17:10-17:25

Sharing experiences from Oligocare: challeges of SBRT planning for multiple target volumes

Ciro Franzese (IT)

17:25-17:40

OligoCare consensus project on combined SBRT and targeted therapy & immunotherapy

Matea Pavic (CH)

17:40-17:45

Closing remarks: Optimising patient follow-up

All